Pharma feed

AbbVie Inc
BioSpace· 26 Jul 2021

The BioMidwest Region Features Lifestyle Bonuses and Cutting-Edge Science

While it may often seem like all of the action happens on the coasts, America’s heartland is home to big players like AbbVie , CSL Behring , and Eli Lilly and Company , and niche innovators like Millendo Therapeutics and Novartis Gene Therapies .

  • AbbVie Inc
  • Biospace
  • CSL Behring GmbH
  • Cost Cutting
  • Press Releases
  • Company Websites
N
Pfizer Inc
Reuters· 26 Jul 2021

Israel weighing COVID booster shots for over 60s before FDA approval

JERUSALEM, July 26 (Reuters) - Israel is considering giving a third shot of the Pfizer (PFE.N)/BioNTech COVID-19 vaccine to its elderly population even before FDA approval in order to help fend off the Delta coronavirus variant, a health official said on Monday.

  • Pfizer Inc
  • US Food and Drug Administration
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Pfizer Inc
Hamilton Spectator· 26 Jul 2021

Pfizer and Moderna urged to expand COVID vaccine studies of children 5 to 11

Pfizer (PFE) and Moderna (MRNA) reportedly are expanding their COVID-19 vaccine studies in children ages five to 11. The Food and Drug Administration told the companies that the initial size and scope of their pediatric studies were inadequate to detect rare side effects.

  • Pfizer Inc
  • Business Expansion
  • News Articles
  • News Websites
N
Johnson & Johnson
Business Live SA· 26 Jul 2021

Aspen releases first batch of J&J vaccines in boost to inoculation drive

National / Health Aspen releases first batch of J&J vaccines in boost to inoculation drive Johnson & Johnson shots with active ingredients from Europe ar to supply SA, AU and EU BL PREMIUM SA’s biggest pharmaceutical manufacturer, Aspen Pharmacare, began supplying the government with Johnson & Johnson (J&J) coronavirus vaccines on Monday, dispatching 1.49-million doses to the department of health in a major boost to the country’s serially delayed inoculation drive.

  • Johnson & Johnson
  • New Offerings
  • News Articles
  • News Websites
N
Biogen Inc
Dakota Financial News· 26 Jul 2021

William Blair Analysts Decrease Earnings Estimates for Biogen Inc. (NASDAQ:BIIB)

Biogen Inc. (NASDAQ:BIIB) – Stock analysts at William Blair lowered their Q4 2021 earnings estimates for Biogen in a report issued on Thursday, July 22nd. William Blair analyst M. Phipps now anticipates that the biotechnology company will post earnings per share of $3.73 for the quarter, down from their prior forecast of $3.84.

  • William Blair & Co LLC
  • Biogen Inc
  • Financial Results
  • News Articles
  • News Websites
N
AstraZeneca PLC
Nasdaq· 26 Jul 2021

What's in the Cards for AstraZeneca (AZN) in Q2 Earnings?

AstraZeneca AZN will report second-quarter 2021 results on Jul 29. In the last reported quarter, the company delivered an earnings surprise of 14.08%. The company’s earnings beat estimates in three of the past four quarters and missed the same once, with the average earnings surprise being 5.25%.

  • AstraZeneca PLC
  • Financial Results
  • News Articles
  • Stock Exchanges
Alexion Pharmaceuticals Inc
AstraZeneca· 26 Jul 2021

Ultomiris recommended for approval in the EU by CHMP for children and adolescents with paroxysmal nocturnal haemoglobinuria

Alexion’s Ultomiris (ravulizumab) has been recommended for marketing authorisation in the European Union (EU) for expanded use to include children and adolescents with paroxysmal nocturnal haemoglobinuria (PNH). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its positive opinion on interim results from the Phase III clinical trial in children and adolescents with PNH, which were recently presented during the European Hematology Association 2021 Virtual Congress.

  • Alexion Pharmaceuticals Inc
  • AstraZeneca PLC
  • Regulatory and Legal
  • Press Releases
  • Company Websites
N
Pfizer Inc
Infobae· 26 Jul 2021

A pedido de la FDA, Pfizer y Moderna amplían el estudio de sus vacunas en niños de 5 a 11 años

Según The New York Times, varias personas familiarizadas con los ensayos dijeron que la FDA manifestó a Pfizer-BioNTech y Moderna que el tamaño y el alcance de sus estudios pediátricos, como se previó inicialmente, eran

  • Pfizer Inc
  • US Food and Drug Administration
  • Regulatory and Legal
  • News Articles
  • News Websites
Pfizer Inc
Sunjournal· 26 Jul 2021

FDA asks Pfizer, Moderna to test their vaccines in more children to help rule out safety issues

Federal regulators have requested that vaccine companies expand their trials to test coronavirus shots in several thousand school-aged children before seeking authorization – a move intended to assess whether a rare inflammation of the heart muscle that has been seen in young adults shortly after vaccination is more common in younger age groups.

  • Pfizer Inc
  • US Food and Drug Administration
  • Sun Journal - Sun Media Group
  • Regulatory and Legal
  • News Articles
  • Company Websites
N
Pfizer Inc
Aerotechnews· 26 Jul 2021

Contract Briefs

U.S. Army Pfizer, N.Y., N.Y., was awarded a $1,351,936,500 modification (P00008) to contract W15QKN-21-C-0012 for the production of vaccine BNT162b2. Bids were solicited via the internet with one received. Work locations and funding will be determined with each order, with an estimated completion date of March 31, 2022.

  • Pfizer Inc
  • Procurement and Sales
  • News Articles
  • News Websites
N
Allergan Inc
Law 360· 26 Jul 2021

Allergan Hits Generic Cos. With Patent Suits Over Viberzi

Law360 (July 26, 2021, 3:00 PM EDT) -- Allergan USA Inc. has filed patent infringement suits in Delaware federal court to stop a number of Indian competitors from making generic versions of its irritable bowel syndrome drug Viberzi.

  • USA Inc.
  • Allergan Inc
  • USA Inc
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Pfizer Inc
The Mandarin· 25 Jul 2021

Berejiklian attempts to call the shots as public anger grows over COVID-19 restrictions

NSW premier Gladys Berejiklian has declared a ‘national emergency’ to redirect Pfizer supplies from other states to COVID hotspots in Sydney but the outcome of a cabinet meeting with state and territory leaders on Friday did not result to allocations of the mRNA vaccine being diverted from other states to NSW.

  • Pfizer Inc
  • Regulatory and Legal
  • News Articles
  • News Websites
Hoffmann-La Roche Ltd
Chugai-Pharm· 25 Jul 2021

F. Hoffmann-La Roche Announces Half Year Results 2021

F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced its half year results 2021 (January 1 – June 30, 2021) on July 22, 2021 (local time). Roche owns 59.89% of Chugai’s outstanding shares (61.16% of the total number of shares issued excluding treasury stock) as of the end of June 2021.

  • Hoffmann-La Roche Ltd
  • F. Hoffmann-La Roche Ltd
  • Roche Products Ltd
  • Chugai Pharmaceutical Co Ltd
  • Financial Results
  • Press Releases
  • Company Websites
N
Pfizer Inc
Trend· 25 Jul 2021

Geographic areas for Covid-19 vaccination to expand in Georgia

153,000 people booked the Pfizer jab in one day, 10,000 slots are still available in regions, said Head of the National Centre for Disease Control and Public Health (NCDC), Amiran Gamkrelidze, Trend reports citing 1tv.ge. 100,000 doses of Pfizer jab is in stock with more to come in stages.

  • Pfizer Inc
  • Business Expansion
  • News Articles
  • News Websites
Pfizer Inc
Corriere Adriatico· 25 Jul 2021

Pfizer «sperimentale fino al 2023», «modifica il Dna», «produce le varianti»: tutte le fake news sul vaccino

A preview of this article is not available. Please click on the headline to read the complete article

  • Pfizer Inc
  • New Offerings
  • News Articles
  • Company Websites
N
WebMD, LLC.
Twitter· 25 Jul 2021

Pfizer's COVID vaccine could gain full government approval by January 2022 at the latest, according to the FDA. https://t.co/zIMc0GlnDq

Pfizer's COVID vaccine could gain full government approval by January 2022 at the latest, according to the FDA. https://t.co/zIMc0GlnDq

FDA Grants Priority Review Status to Pfizer Vaccine
The Pfizer vaccine has been administered to people 16 and up under an emergency use authorization since mid-December. It was the first vaccine authorized by the government and is …
  • WebMD, LLC.
  • US Food and Drug Administration
  • Pfizer Inc
  • Regulatory and Legal
  • Social Updates
  • Social Media
N
Pfizer Inc
Ilgazzettino· 25 Jul 2021

Pfizer «sperimentale fino al 2023», «modifica il Dna», «produce le varianti»: tutte le fake news sul vaccino

Tra i timori che fermano molte persone a iniettarsi il vaccino c'è l'aspetto che finora sono stati approvati «in via d'emergenza». Ma c'è una grande differenza tra vaccini approvati in via d'emergenza e sperimentali. Insomma, sul conto dei vaccini circolano una serie di bufale, fake news, che fonti ufficiali (a partire dall'Iss) mettono a tacere.

  • Pfizer Inc
  • ESG
  • News Articles
  • News Websites
Pfizer Inc
Il Globo· 25 Jul 2021

Pfizer permesso ai più giovani

L’ambasciatore giapponese, in un intervento al Circolo nazionale della stampa sollecita una maggiore collaborazione militare con l’Australia Australian News / L’ambasciatore del Giappone in Australia ha espresso fermo sostegno all’approccio del governo di Canberra verso la Cina, specialmente nel modo in cui ha resistito a pressioni economiche e sanzioni commerciali.

  • Pfizer Inc
  • Artificial Intelligence
  • News Articles
  • Company Websites
N
Pfizer Inc
Yahoo· 25 Jul 2021

Fact check: Pfizer, Moderna vaccines don't pose 'any obvious safety signals' in pregnancy, study found

The different coronavirus vaccines have one thing in common: They've been met with skepticism by some Americans, who have often shared misinformation about their potential side effects.Many of these false claims center around pregnant women. "The CDC have been caught manipulating data to justify giving pregnant women the COVID jab,"an image posted July 10 on Instagramsays.

  • Pfizer Inc
  • New Offerings
  • News Articles
  • News Websites
N
Foundation Academies
Twitter· 25 Jul 2021

Happening Today, Sunday, 7/25 from 11 a.m. to 5 p.m. - Free "Grateful for the Shot" event hosted by Shiloh Baptist Church at 416 Bellevue Ave. First and second doses of Pfizer (12+) and the single-dose Johnson & Johnson vaccine (18+) will be available. Walk-ins welcome! #covid19

Happening Today, Sunday, 7/25 from 11 a.m. to 5 p.m. - Free "Grateful for the Shot" event hosted by Shiloh Baptist Church at 416 Bellevue Ave. First and second doses of Pfizer (12+) and the single-dose Johnson & Johnson vaccine (18+) will be available. Walk-ins welcome! #covid19

  • Foundation Academies
  • Pfizer Inc
  • Events
  • Social Updates
  • Social Media
Pfizer Inc
Corriere Adriatico· 25 Jul 2021

Pfizer «sperimentale fino al 2023», «modifica il Dna», «produce le varianti»: tutte le fake news sul vaccino

A preview of this article is not available. Please click on the headline to read the complete article

  • Pfizer Inc
  • New Offerings
  • News Articles
  • Company Websites
Pfizer Inc
Corriere Adriatico· 25 Jul 2021

Pfizer «sperimentale fino al 2023», «modifica il Dna», «produce le varianti»: tutte le fake news sul vaccino

A preview of this article is not available. Please click on the headline to read the complete article

  • Pfizer Inc
  • New Offerings
  • News Articles
  • Company Websites
N
Pfizer Inc
Westernstandardonline· 25 Jul 2021

Feds considered national identity cards

A Calgary mother has still not fully recovered from an adverse reaction she received from the Pfizer COVID-19 jab two months ago. Sharlene Karkut, a stay-at-home mom in Calgary, told the Western Standard her problems began within a half hour of getting her first shot on May 21.

  • Pfizer Inc
  • Western Standard LLC
  • Regulatory and Legal
  • News Articles
  • News Websites
N
Pfizer Inc
Qz· 25 Jul 2021

Pfizer and BioNTech's partnership in Africa, News from Africa, July 2021 — Quartz Africa Weekly Brief — Quartz

Hi Quartz Africa readers! The coronavirus pandemic has been harsh for Africa’s $50 billion tourism industry, with the fall-off in foreign visitors likely to knock out more than 6% of countries’ GDP on average in 2021, according to the UN.

  • Pfizer Inc
  • Partnerships and Alliances
  • News Articles
  • News Websites
N
Pfizer Inc
Oregonlive· 25 Jul 2021

Readers respond: Big Pharma ads a waste of dollars

I have long been critical of Big Pharma running costly TV ads promoting their ridiculously overpriced products, mostly to treat conditions that affect a relatively small percentage of the population. A 2015 article from The Pharmacy Times reported that even back then, Pfizer alone had spent more than $1 billion in advertising the previous year.

  • Pfizer Inc
  • ESG
  • News Articles
  • News Websites
1 2 3 4 5